Precision BioSciences Wins Stay of Patent Litigation Brought by CELLECTIS SA

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc., today announced that the United States District Court for the Eastern District of North Carolina has granted Precision’s request to stay patent infringement litigation brought against Precision by Cellectis, SA (Alternext: ALCLS). The Court has ordered that all proceedings be suspended pending final resolution and appeal of the U.S. Patent and Trademark Office (PTO) reexaminations of U.S. Patent Nos. 6,610,545 and 7,309,605. Previously, Precision announced that the PTO had issued non-final Actions Closing Prosecution in the reexamination proceedings for both patents in which the PTO, for the second time, rejected all claims asserted against Precision in the litigation.